| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 3.66e-05 | 27 | 48 | 3 | GO:0004683 | |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine kinase activity | 2.52e-04 | 10 | 48 | 2 | GO:0009931 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 1.21e-07 | 5 | 49 | 3 | GO:0005954 | |
| GeneOntologyCellularComponent | cell cortex | 2.20e-04 | 371 | 49 | 6 | GO:0005938 | |
| Domain | CaMKII_AD | 6.36e-08 | 4 | 48 | 3 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 6.36e-08 | 4 | 48 | 3 | IPR013543 | |
| Domain | - | 4.47e-06 | 13 | 48 | 3 | 3.10.450.50 | |
| Domain | NTF2-like_dom | 7.09e-06 | 15 | 48 | 3 | IPR032710 | |
| Domain | - | 9.64e-05 | 6 | 48 | 2 | 3.90.1290.10 | |
| Domain | GAR | 9.64e-05 | 6 | 48 | 2 | PS51460 | |
| Domain | - | 9.64e-05 | 6 | 48 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 9.64e-05 | 6 | 48 | 2 | IPR003108 | |
| Domain | GAS2 | 9.64e-05 | 6 | 48 | 2 | PF02187 | |
| Domain | GAS2 | 9.64e-05 | 6 | 48 | 2 | SM00243 | |
| Domain | Plectin_repeat | 1.35e-04 | 7 | 48 | 2 | IPR001101 | |
| Domain | Plectin | 1.35e-04 | 7 | 48 | 2 | PF00681 | |
| Domain | PLEC | 1.35e-04 | 7 | 48 | 2 | SM00250 | |
| Domain | CH | 6.22e-04 | 65 | 48 | 3 | SM00033 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 7.41e-04 | 69 | 48 | 3 | IPR020636 | |
| Domain | CH | 7.73e-04 | 70 | 48 | 3 | PF00307 | |
| Domain | - | 8.05e-04 | 71 | 48 | 3 | 1.10.418.10 | |
| Domain | CH | 8.73e-04 | 73 | 48 | 3 | PS50021 | |
| Domain | CH-domain | 9.45e-04 | 75 | 48 | 3 | IPR001715 | |
| Domain | Actinin_actin-bd_CS | 1.58e-03 | 23 | 48 | 2 | IPR001589 | |
| Domain | Spectrin | 1.58e-03 | 23 | 48 | 2 | PF00435 | |
| Domain | ACTININ_2 | 1.58e-03 | 23 | 48 | 2 | PS00020 | |
| Domain | ACTININ_1 | 1.58e-03 | 23 | 48 | 2 | PS00019 | |
| Domain | Spectrin_repeat | 2.51e-03 | 29 | 48 | 2 | IPR002017 | |
| Domain | Kinase-like_dom | 2.53e-03 | 542 | 48 | 6 | IPR011009 | |
| Domain | Spectrin/alpha-actinin | 3.05e-03 | 32 | 48 | 2 | IPR018159 | |
| Domain | SPEC | 3.05e-03 | 32 | 48 | 2 | SM00150 | |
| Domain | FERM_M | 6.23e-03 | 46 | 48 | 2 | PF00373 | |
| Domain | - | 7.04e-03 | 49 | 48 | 2 | 1.20.80.10 | |
| Domain | FERM_central | 7.04e-03 | 49 | 48 | 2 | IPR019748 | |
| Domain | FERM_domain | 7.04e-03 | 49 | 48 | 2 | IPR000299 | |
| Domain | FERM_1 | 7.32e-03 | 50 | 48 | 2 | PS00660 | |
| Domain | FERM_2 | 7.32e-03 | 50 | 48 | 2 | PS00661 | |
| Domain | FERM_3 | 7.32e-03 | 50 | 48 | 2 | PS50057 | |
| Domain | Band_41_domain | 7.32e-03 | 50 | 48 | 2 | IPR019749 | |
| Domain | B41 | 7.32e-03 | 50 | 48 | 2 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 7.32e-03 | 50 | 48 | 2 | IPR014352 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.66e-06 | 10 | 35 | 3 | M26910 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 2.24e-06 | 87 | 35 | 5 | M12467 | |
| Pathway | PID_IFNG_PATHWAY | 2.73e-06 | 40 | 35 | 4 | M161 | |
| Pathway | WP_ERBB_SIGNALING | 2.95e-06 | 92 | 35 | 5 | M39715 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 5.01e-06 | 14 | 35 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 5.01e-06 | 14 | 35 | 3 | M47388 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 6.25e-06 | 15 | 35 | 3 | M47385 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 8.11e-06 | 113 | 35 | 5 | M39669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 9.31e-06 | 17 | 35 | 3 | M47387 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 1.32e-05 | 19 | 35 | 3 | M47957 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 1.32e-05 | 19 | 35 | 3 | MM15473 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 1.55e-05 | 20 | 35 | 3 | M17670 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.81e-05 | 21 | 35 | 3 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 1.81e-05 | 21 | 35 | 3 | M27944 | |
| Pathway | KEGG_GLIOMA | 1.94e-05 | 65 | 35 | 4 | M1835 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 2.09e-05 | 22 | 35 | 3 | MM15104 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.40e-05 | 23 | 35 | 3 | MM14953 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.40e-05 | 23 | 35 | 3 | M47512 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 2.40e-05 | 23 | 35 | 3 | M27949 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 2.60e-05 | 70 | 35 | 4 | M3115 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.74e-05 | 24 | 35 | 3 | M47509 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.11e-05 | 25 | 35 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.11e-05 | 25 | 35 | 3 | M47511 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 4.40e-05 | 28 | 35 | 3 | M837 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 4.40e-05 | 28 | 35 | 3 | M47508 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 4.90e-05 | 29 | 35 | 3 | MM15028 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 6.01e-05 | 31 | 35 | 3 | M7223 | |
| Pathway | PID_AVB3_OPN_PATHWAY | 6.01e-05 | 31 | 35 | 3 | M63 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 6.62e-05 | 32 | 35 | 3 | M27455 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 6.62e-05 | 32 | 35 | 3 | M27900 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 7.27e-05 | 33 | 35 | 3 | M39875 | |
| Pathway | REACTOME_RAF_ACTIVATION | 7.96e-05 | 34 | 35 | 3 | M27556 | |
| Pathway | REACTOME_RAF_ACTIVATION | 8.69e-05 | 35 | 35 | 3 | MM15271 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 8.69e-05 | 35 | 35 | 3 | MM15109 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 9.75e-05 | 98 | 35 | 4 | M965 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.03e-04 | 37 | 35 | 3 | M749 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.11e-04 | 38 | 35 | 3 | M27255 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.40e-04 | 41 | 35 | 3 | M512 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 1.73e-04 | 44 | 35 | 3 | M39845 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.73e-04 | 44 | 35 | 3 | M27934 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 1.85e-04 | 45 | 35 | 3 | M27623 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 2.11e-04 | 47 | 35 | 3 | M39531 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 2.57e-04 | 126 | 35 | 4 | M16763 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.19e-04 | 54 | 35 | 3 | M26911 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.19e-04 | 54 | 35 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 3.19e-04 | 54 | 35 | 3 | MM15202 | |
| Pathway | PID_FGF_PATHWAY | 3.37e-04 | 55 | 35 | 3 | M276 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 3.37e-04 | 55 | 35 | 3 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 3.74e-04 | 57 | 35 | 3 | MM15643 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 3.84e-04 | 140 | 35 | 4 | M42572 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.27e-04 | 144 | 35 | 4 | MM14501 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 5.03e-04 | 63 | 35 | 3 | M27862 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 5.12e-04 | 151 | 35 | 4 | M19428 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 5.51e-04 | 65 | 35 | 3 | M38994 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 8.38e-04 | 75 | 35 | 3 | M39568 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 9.09e-04 | 176 | 35 | 4 | MM15718 | |
| Pathway | PID_EPHA2_FWD_PATHWAY | 9.97e-04 | 19 | 35 | 2 | M273 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.05e-03 | 183 | 35 | 4 | M997 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 1.09e-03 | 82 | 35 | 3 | M27626 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.16e-03 | 188 | 35 | 4 | MM15828 | |
| Pathway | WP_TCELL_RECEPTOR_SIGNALING | 1.42e-03 | 90 | 35 | 3 | M39725 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.42e-03 | 90 | 35 | 3 | M6467 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.51e-03 | 92 | 35 | 3 | MM14951 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.60e-03 | 205 | 35 | 4 | M752 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.61e-03 | 94 | 35 | 3 | M2843 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.78e-03 | 211 | 35 | 4 | MM14502 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.87e-03 | 26 | 35 | 2 | MM1371 | |
| Pathway | KEGG_MELANOGENESIS | 1.98e-03 | 101 | 35 | 3 | M7761 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.98e-03 | 101 | 35 | 3 | M27253 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.98e-03 | 101 | 35 | 3 | M1979 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 2.02e-03 | 27 | 35 | 2 | M45550 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.09e-03 | 103 | 35 | 3 | MM15196 | |
| Pathway | WP_DRAVET_SYNDROME | 2.17e-03 | 28 | 35 | 2 | M45519 | |
| Pathway | REACTOME_DAP12_SIGNALING | 2.33e-03 | 29 | 35 | 2 | M27171 | |
| Pathway | KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 2.39e-03 | 108 | 35 | 3 | M9904 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 2.52e-03 | 110 | 35 | 3 | MM15977 | |
| Pathway | REACTOME_DAP12_SIGNALING | 2.66e-03 | 31 | 35 | 2 | MM14886 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 2.72e-03 | 113 | 35 | 3 | M16817 | |
| Pathway | PID_NETRIN_PATHWAY | 2.83e-03 | 32 | 35 | 2 | M108 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 2.93e-03 | 116 | 35 | 3 | M2164 | |
| Pathway | WP_FRAGILE_X_SYNDROME | 3.30e-03 | 121 | 35 | 3 | M39804 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 3.38e-03 | 35 | 35 | 2 | MM15144 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 3.38e-03 | 35 | 35 | 2 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 3.38e-03 | 35 | 35 | 2 | M773 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 3.58e-03 | 36 | 35 | 2 | M271 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 4.04e-03 | 130 | 35 | 3 | M27454 | |
| Pathway | PID_ECADHERIN_NASCENT_AJ_PATHWAY | 4.19e-03 | 39 | 35 | 2 | M156 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 4.32e-03 | 270 | 35 | 4 | M15514 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 4.40e-03 | 40 | 35 | 2 | M39695 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 4.49e-03 | 273 | 35 | 4 | M983 | |
| Pathway | PID_ERBB1_INTERNALIZATION_PATHWAY | 4.62e-03 | 41 | 35 | 2 | M214 | |
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 10381553 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 1.12e-08 | 4 | 50 | 3 | 17367784 | |
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 11889801 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 11013247 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 18218981 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 21209221 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 14722083 | ||
| Pubmed | Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. | 2.79e-08 | 5 | 50 | 3 | 16436603 | |
| Pubmed | Multiple kinases regulate mafA expression in the pancreatic beta cell line MIN6. | 5.57e-08 | 6 | 50 | 3 | 18948074 | |
| Pubmed | Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II. | 9.75e-08 | 7 | 50 | 3 | 9115241 | |
| Pubmed | 1.56e-07 | 8 | 50 | 3 | 11264466 | ||
| Pubmed | 1.56e-07 | 8 | 50 | 3 | 20668654 | ||
| Pubmed | 2.33e-07 | 9 | 50 | 3 | 12660151 | ||
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 28361052 | ||
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 19776387 | ||
| Pubmed | 6.09e-07 | 12 | 50 | 3 | 8615909 | ||
| Pubmed | 6.09e-07 | 12 | 50 | 3 | 8665664 | ||
| Pubmed | 6.09e-07 | 12 | 50 | 3 | 12815021 | ||
| Pubmed | 1.01e-06 | 14 | 50 | 3 | 10373510 | ||
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 1.26e-06 | 15 | 50 | 3 | 14622581 | |
| Pubmed | 1.26e-06 | 15 | 50 | 3 | 9481670 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 21884935 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 32149607 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25650780 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 11002341 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 27496951 | ||
| Pubmed | Alterations of L-type calcium current and cardiac function in CaMKII{delta} knockout mice. | 2.03e-06 | 2 | 50 | 2 | 20538682 | |
| Pubmed | CaMK-II oligomerization potential determined using CFP/YFP FRET. | 2.03e-06 | 2 | 50 | 2 | 16185778 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 18703025 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 17184923 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 9523577 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 11710563 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 34908526 | ||
| Pubmed | De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability. | 2.03e-06 | 2 | 50 | 2 | 29100089 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 21252154 | ||
| Pubmed | Control of memory formation through regulated expression of a CaMKII transgene. | 2.03e-06 | 2 | 50 | 2 | 8939850 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 23316062 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 21752990 | ||
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 2.25e-06 | 18 | 50 | 3 | 18311135 | |
| Pubmed | Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module. | 5.68e-06 | 177 | 50 | 5 | 22560297 | |
| Pubmed | Identification of novel human tumor cell-specific CaMK-II variants. | 6.07e-06 | 3 | 50 | 2 | 9060999 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 10819240 | ||
| Pubmed | The oxidation-resistant CaMKII-MM281/282VV mutation does not prevent arrhythmias in CPVT1. | 6.07e-06 | 3 | 50 | 2 | 34558218 | |
| Pubmed | Characterization of a calmodulin kinase II inhibitor protein in brain. | 6.07e-06 | 3 | 50 | 2 | 9724800 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 32776935 | ||
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 6.07e-06 | 3 | 50 | 2 | 12399109 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 29615706 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 16247765 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 11867691 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 20844140 | ||
| Pubmed | Calcium regulation of GM-CSF by calmodulin-dependent kinase II phosphorylation of Ets1. | 6.07e-06 | 3 | 50 | 2 | 12475968 | |
| Pubmed | CAMK2-Dependent Signaling in Neurons Is Essential for Survival. | 6.07e-06 | 3 | 50 | 2 | 31064859 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 12619878 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 22427508 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 30905780 | ||
| Pubmed | Cellular Mechanisms of the Anti-Arrhythmic Effect of Cardiac PDE2 Overexpression. | 6.07e-06 | 3 | 50 | 2 | 34062838 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 9882483 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 21610080 | ||
| Pubmed | 8.33e-06 | 963 | 50 | 9 | 28671696 | ||
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 8.93e-06 | 28 | 50 | 3 | 31600191 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 25644714 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 24949568 | ||
| Pubmed | Autophosphorylated CaMKIIalpha acts as a scaffold to recruit proteasomes to dendritic spines. | 1.21e-05 | 4 | 50 | 2 | 20178748 | |
| Pubmed | Arc ubiquitination regulates endoplasmic reticulum-mediated Ca2+ release and CaMKII signaling. | 1.21e-05 | 4 | 50 | 2 | 36998269 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 15312654 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 8954775 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 11468283 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 28130256 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 11751951 | ||
| Pubmed | Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. | 2.02e-05 | 5 | 50 | 2 | 11526404 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 11160423 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 19671701 | ||
| Pubmed | PTPBR7 binding proteins in myelinating neurons of the mouse brain. | 2.02e-05 | 5 | 50 | 2 | 21850207 | |
| Pubmed | PTENα Modulates CaMKII Signaling and Controls Contextual Fear Memory and Spatial Learning. | 2.02e-05 | 5 | 50 | 2 | 28636948 | |
| Pubmed | Epac2 mediates cardiac β1-adrenergic-dependent sarcoplasmic reticulum Ca2+ leak and arrhythmia. | 2.02e-05 | 5 | 50 | 2 | 23363625 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 16120608 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 26539091 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 8940188 | ||
| Pubmed | Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. | 3.03e-05 | 6 | 50 | 2 | 11972023 | |
| Pubmed | Evidence for direct protein kinase-C mediated modulation of N-methyl-D-aspartate receptor current. | 3.03e-05 | 6 | 50 | 2 | 11306676 | |
| Pubmed | A β(IV)-spectrin/CaMKII signaling complex is essential for membrane excitability in mice. | 3.03e-05 | 6 | 50 | 2 | 20877009 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 23615713 | ||
| Pubmed | 3.06e-05 | 251 | 50 | 5 | 27507650 | ||
| Pubmed | 3.08e-05 | 421 | 50 | 6 | 36976175 | ||
| Pubmed | 3.76e-05 | 130 | 50 | 4 | 12421765 | ||
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 34932950 | ||
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 12147342 | ||
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 23656756 | ||
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 27474268 | ||
| Pubmed | Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome. | 4.92e-05 | 49 | 50 | 3 | 27352031 | |
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 17202341 | ||
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 28130356 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 7.79e-05 | 498 | 50 | 6 | 36634849 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 8.37e-05 | 736 | 50 | 7 | 29676528 | |
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 19332541 | ||
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 1319776 | ||
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 20124353 | ||
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 21491429 | ||
| Pubmed | Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors. | 1.10e-04 | 11 | 50 | 2 | 39256359 | |
| Pubmed | The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. | 1.10e-04 | 11 | 50 | 2 | 16815997 | |
| Interaction | CAMK2N1 interactions | 1.50e-06 | 10 | 48 | 3 | int:CAMK2N1 | |
| Interaction | KALRN interactions | 3.21e-06 | 96 | 48 | 5 | int:KALRN | |
| Interaction | PDE4A interactions | 4.92e-05 | 30 | 48 | 3 | int:PDE4A | |
| Interaction | C6orf141 interactions | 6.79e-05 | 92 | 48 | 4 | int:C6orf141 | |
| Interaction | LCK interactions | 1.05e-04 | 463 | 48 | 7 | int:LCK | |
| Interaction | CIBAR2 interactions | 1.16e-04 | 7 | 48 | 2 | int:CIBAR2 | |
| Interaction | CAMK2N2 interactions | 1.16e-04 | 7 | 48 | 2 | int:CAMK2N2 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.01e-04 | 8 | 35 | 2 | 939 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.31e-06 | 190 | 50 | 5 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.56e-06 | 194 | 50 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.63e-06 | 195 | 50 | 5 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.76e-06 | 197 | 50 | 5 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.76e-06 | 197 | 50 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.76e-06 | 197 | 50 | 5 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Cpne7|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.36e-05 | 149 | 50 | 4 | 8638b3819193d11411df58964069fec583f617f4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 158 | 50 | 4 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 158 | 50 | 4 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 3.36e-05 | 163 | 50 | 4 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-05 | 164 | 50 | 4 | 6fb2136168f430babfeb81ca7e151ca7a8092ec4 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.87e-05 | 169 | 50 | 4 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 169 | 50 | 4 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.24e-05 | 173 | 50 | 4 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-05 | 175 | 50 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-05 | 176 | 50 | 4 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-05 | 177 | 50 | 4 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.73e-05 | 178 | 50 | 4 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | Endothelial-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.73e-05 | 178 | 50 | 4 | 2f2602b9305d55f25afa9861dd6c6347ae179337 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.73e-05 | 178 | 50 | 4 | 674ee5095b98929c29e4f6bd56029a336cc4a38c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.94e-05 | 180 | 50 | 4 | 5391d23817f5cc88a0871ddb98968897c839f464 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.16e-05 | 182 | 50 | 4 | d6740bca2b974122b8451989365a94a81140afd1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-05 | 183 | 50 | 4 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.38e-05 | 184 | 50 | 4 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.38e-05 | 184 | 50 | 4 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.50e-05 | 185 | 50 | 4 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.50e-05 | 185 | 50 | 4 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.50e-05 | 185 | 50 | 4 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.50e-05 | 185 | 50 | 4 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-05 | 185 | 50 | 4 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-05 | 185 | 50 | 4 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 186 | 50 | 4 | 744bf39af2fb5a7454477174d7755a6d78cd279f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.85e-05 | 188 | 50 | 4 | 6c7ce6e28e4433092605880acf127833e7b66ebe | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 6.10e-05 | 190 | 50 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.22e-05 | 191 | 50 | 4 | 7a4fe96989f72159385270c712342ba3e1ca6fc3 | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 6.22e-05 | 191 | 50 | 4 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.22e-05 | 191 | 50 | 4 | f1935e8f8467a2bc30588b7f2cc3b94e9c83b268 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.22e-05 | 191 | 50 | 4 | c023ca893ceae19b54967096f6e2588dc39fa268 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.22e-05 | 191 | 50 | 4 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.22e-05 | 191 | 50 | 4 | 1161e465c50c2071764279e01cf08b1048cce0e3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.48e-05 | 193 | 50 | 4 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-05 | 193 | 50 | 4 | d5930f7bd9b299f792212d40a3272a37adf64a82 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.48e-05 | 193 | 50 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.74e-05 | 195 | 50 | 4 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | Mild/Remission-B_naive-8|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.74e-05 | 195 | 50 | 4 | 0a3221e4d1fa31a35868bdda0f0cc873c233b407 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.74e-05 | 195 | 50 | 4 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.88e-05 | 196 | 50 | 4 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.88e-05 | 196 | 50 | 4 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.88e-05 | 196 | 50 | 4 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 7.01e-05 | 197 | 50 | 4 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 7.01e-05 | 197 | 50 | 4 | 44f37a98f07c3e46a7e8fd3b64c2b2b44d5bbe40 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.01e-05 | 197 | 50 | 4 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.15e-05 | 198 | 50 | 4 | 36c97eb71b89bac01cabd6a8b728e5a20e52d2a3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.15e-05 | 198 | 50 | 4 | 50dfe6efca76ea9683a19b6bff59cb5030d346f1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.15e-05 | 198 | 50 | 4 | 5b9a7b9f53a3d9cf8d6e6a7c1c94514b22cf9fa8 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.15e-05 | 198 | 50 | 4 | 6e314dc820db9c53fe7fc7c96bed4d7d9a325160 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.15e-05 | 198 | 50 | 4 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD8+_Tcm|Leuk-UTI / Disease, condition lineage and cell class | 7.29e-05 | 199 | 50 | 4 | 6a1d84f61e1efaab541910926d6911122372659f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.29e-05 | 199 | 50 | 4 | 1761669ec514fdb4175042f11b9a31fa5687fc2b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-05 | 199 | 50 | 4 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.29e-05 | 199 | 50 | 4 | 5f350d9c7da9ac111bf22623dd4fed7f7983c9fc | |
| ToppCell | mild-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.44e-05 | 200 | 50 | 4 | a195bc6784346f706d4cd5b740adac1d950ce88a | |
| ToppCell | mild-NK_CD56bright|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.44e-05 | 200 | 50 | 4 | 6de701985a0b92a7dece1b0e4a76e13756ccc0dd | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, condition lineage and cell class | 7.44e-05 | 200 | 50 | 4 | 511e642575182fb678df6791ee6539b0ced3eb17 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.44e-05 | 200 | 50 | 4 | 363a8cebf2ace820661bcb87c7941f6671f8e5f3 | |
| ToppCell | severe-NK_CD56bright|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.44e-05 | 200 | 50 | 4 | 82818ab1796fdd0b8be02b341818897595eed841 | |
| ToppCell | severe-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.44e-05 | 200 | 50 | 4 | 2e67068b98696c313b815a2f0c98643f892e8bc0 | |
| ToppCell | COVID-19_Severe-Neu_3|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 3.56e-04 | 123 | 50 | 3 | 4c20c025b6f19f075a13282288fc537e6e186217 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.52e-04 | 143 | 50 | 3 | 4622c221b5d2d4cd4f37e4f81662e073924e1507 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.52e-04 | 143 | 50 | 3 | 9836a040a2ebcf6f05431e658a7b8fd566621452 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Tgfb1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.75e-04 | 145 | 50 | 3 | 84d50a13b48d50c16e768422908e371a55972d0e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Met|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.75e-04 | 145 | 50 | 3 | 8abbc781f5f69f039617c29a5589d7b6950c2c40 | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.10e-04 | 148 | 50 | 3 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-04 | 149 | 50 | 3 | 24a7538b54b2a5291503c7493fefed4e45e8d710 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.22e-04 | 149 | 50 | 3 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-04 | 149 | 50 | 3 | cc6224c6b79f43b97adc1ce48ca4906bff2ad318 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 6.22e-04 | 149 | 50 | 3 | 078e1e5765e476ba85c23fb8f6892b6698cbcbdb | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.35e-04 | 150 | 50 | 3 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 6.47e-04 | 151 | 50 | 3 | 5906562efd36fbcb91f96e0a0d3a8fe999ba1e79 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.60e-04 | 152 | 50 | 3 | b6a7453fbf9f898e4f222b215907c9a110baa2f6 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.60e-04 | 152 | 50 | 3 | ca23261d8ef263cc697b8d7e7cb2afec8bc564f2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-04 | 153 | 50 | 3 | 79c4f4ccdc8249c8461075c73491bc3b2d13344a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.98e-04 | 155 | 50 | 3 | 5687416773809b8c478567bc54310af102b3029a | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.11e-04 | 156 | 50 | 3 | c11ca6b1b5029c15aab91273cece70a487287839 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.38e-04 | 158 | 50 | 3 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-04 | 159 | 50 | 3 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-04 | 159 | 50 | 3 | d2de9391b00b6c47f5fe28a1bad6da2097107ee0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-04 | 159 | 50 | 3 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-04 | 159 | 50 | 3 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-04 | 159 | 50 | 3 | da6b7f8039adc19839d6c090a0b3d68fb6445a79 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 7.51e-04 | 159 | 50 | 3 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.65e-04 | 160 | 50 | 3 | 1a9329d8183296f36928bd9e96f10db9f04ce326 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.65e-04 | 160 | 50 | 3 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.65e-04 | 160 | 50 | 3 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.65e-04 | 160 | 50 | 3 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.65e-04 | 160 | 50 | 3 | f843287ed57d2d5a3b3f6dfb03b6934e330e6645 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|T_cell / Lineage, cell class and subclass | 7.65e-04 | 160 | 50 | 3 | 66fe86d2f37983761141e5bb3de127f0b4bb0951 | |
| ToppCell | Severe-Lymphoid-NK-|Severe / Condition, Lineage, Cell class and cell subclass | 7.65e-04 | 160 | 50 | 3 | d276c6cb8317d5fb19e7b4fe5238abaf0272d4c6 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.79e-04 | 161 | 50 | 3 | f470b662566131dfe69a2fd01186ac8491196396 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.79e-04 | 161 | 50 | 3 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| Drug | K-II | 2.19e-06 | 96 | 50 | 5 | CID000129400 | |
| Drug | SR 27417 | 1.11e-05 | 20 | 50 | 3 | CID000119368 | |
| Disease | heart conduction disease (implicated_via_orthology) | 2.06e-05 | 32 | 49 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 9.42e-05 | 447 | 49 | 6 | C3714756 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.82e-04 | 206 | 49 | 4 | C0152013 | |
| Disease | squamous cell carcinoma (is_marker_for) | 4.54e-04 | 19 | 49 | 2 | DOID:1749 (is_marker_for) | |
| Disease | Adenocarcinoma of large intestine | 5.52e-04 | 96 | 49 | 3 | C1319315 | |
| Disease | status epilepticus (implicated_via_orthology) | 5.56e-04 | 21 | 49 | 2 | DOID:1824 (implicated_via_orthology) | |
| Disease | Coronary heart disease | 7.28e-04 | 24 | 49 | 2 | C0010068 | |
| Disease | breast cancer (implicated_via_orthology) | 7.91e-04 | 25 | 49 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | cataract (is_implicated_in) | 8.56e-04 | 26 | 49 | 2 | DOID:83 (is_implicated_in) | |
| Disease | Alcoholic Intoxication, Chronic | 1.02e-03 | 268 | 49 | 4 | C0001973 | |
| Disease | PR interval | 1.35e-03 | 495 | 49 | 5 | EFO_0004462 | |
| Disease | IGA Glomerulonephritis | 1.46e-03 | 34 | 49 | 2 | C0017661 | |
| Disease | cerebrospinal fluid clusterin measurement | 1.55e-03 | 35 | 49 | 2 | EFO_0007657 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKHLWLLFPCHRLAS | 86 | O76042 | |
| SWSHRAVVHFVVPVK | 781 | Q6L9W6 | |
| LTVSSLQCHRHKPWR | 341 | P39086 | |
| IAPLFHTICLIWSHS | 361 | Q96DT5 | |
| ARHFWTKICKPVLHQ | 196 | Q9UBU2 | |
| TPCVSRLVTGHHLWA | 1706 | Q96SN8 | |
| TNVAHWTTPSLKCIR | 81 | Q13261 | |
| AICHPDSITTIKHWI | 6991 | Q03001 | |
| TSCVHWKSIIDHLLT | 1986 | Q9Y3R5 | |
| IVPWKVFRQCLHEVH | 191 | Q13191 | |
| HPVLKRSSAHVSVVW | 911 | P38570 | |
| PWLHECLIRFSKSVS | 706 | Q6N069 | |
| TCPLSWVQRVHAHKA | 591 | Q9P265 | |
| WCVPHLSKPNHTLVL | 96 | Q96PP9 | |
| TLSCHSHLRFVIWTI | 46 | Q9H7L2 | |
| QIWRHPTLCHSKEGI | 946 | Q8IVE3 | |
| LWSHRHYCVTIPEIL | 551 | P42336 | |
| HPDCITTIKHWITII | 6841 | Q9UPN3 | |
| HLLPWVKCTTVFRSH | 16 | P54886 | |
| IHIRSKTSVPHHVVW | 46 | C9JQL5 | |
| HSCTTAPLSRKSHIW | 1386 | Q5SYB0 | |
| THVERPFRVASLCWH | 56 | Q96RY7 | |
| ALKHPWICQRSTVAS | 266 | Q13557 | |
| IWHISTIPVHVLFFS | 286 | Q96FM1 | |
| LHSSFTFWVPLCGHR | 161 | O76001 | |
| HIKTWVTLFIGHTIC | 1251 | Q6ZUA9 | |
| ITAHEALKHPWVCQR | 261 | Q13554 | |
| RVSHFLPWIRSHTKE | 411 | P00749 | |
| HLFHSSCILPWLSKT | 96 | Q9P0P0 | |
| ISWFLCPFHLSVARH | 211 | Q6DKI1 | |
| PWQHTTLSVLRKHFE | 946 | Q9P2J5 | |
| SRPHSWHVAKLLEGC | 96 | Q9ULL8 | |
| KVSRVEFLPVHWHSS | 491 | Q9Y6Y8 | |
| TKVSHIPSSRWALVC | 301 | Q6IE81 | |
| LKHPWISHRSTVASC | 266 | Q9UQM7 | |
| PLFVSDGKWHHICVT | 301 | P47972 | |
| WKHTEVFCSIPSRSL | 216 | Q9HAY6 | |
| HIITIHCLNTPRWTS | 1616 | Q17RW2 | |
| ISRLAHTWERLPHKV | 766 | O95398 | |
| FISITHVHRTKPLWR | 1246 | Q12767 | |
| WTIRKLCHAAFLPSV | 41 | Q9HCF6 | |
| FLLAHTRHPSSIWLC | 351 | P41440 | |
| FHWCSPFVRHKKIHT | 266 | O95780 | |
| CTHRFHRKCVDPWLL | 311 | Q9ULT6 | |
| VFKKIERHSIHWPCR | 236 | P13010 | |
| ECVSVHPHWKVRLEL | 296 | O43156 | |
| WRHIPKSHSSSILEV | 701 | Q70EL1 | |
| LIHCKVLPTNHRVTW | 11 | Q9UKW4 | |
| PLRTHWTGVCTKKVH | 76 | Q68DI1 | |
| SLLDAHTWTKSCRPI | 126 | Q8NEJ0 | |
| LIHPLWVLTAAHCKK | 51 | Q92876 |